|
CTTNBP2NL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.169800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.526020E-01 |
| Normal-vs-Stage2 |
5.988600E-01 |
| Normal-vs-Stage3 |
5.108200E-01 |
| Normal-vs-Stage4 |
9.424000E-02 |
| Stage1-vs-Stage2 |
5.401800E-01 |
| Stage1-vs-Stage3 |
8.480600E-03 |
| Stage1-vs-Stage4 |
3.831200E-04 |
| Stage2-vs-Stage3 |
2.769800E-01 |
| Stage2-vs-Stage4 |
5.760400E-02 |
| Stage3-vs-Stage4 |
2.231400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.249600E-01 |
| Normal-vs-AfricanAmerican |
2.351400E-01 |
| Normal-vs-Asian |
2.517600E-02 |
| Caucasian-vs-AfricanAmerican |
5.319900E-02 |
| Caucasian-vs-Asian |
2.550000E-02 |
| AfricanAmerican-vs-Asian |
9.283300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.276800E-01 |
| Normal-vs-Female |
5.584400E-01 |
| Male-vs-Female |
5.957000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.354000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.890200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.928600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.812040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.311600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.030800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.919700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.735800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.929700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.947410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.436280E-02 |
| Normal-vs-Grade 2 |
5.245500E-02 |
| Normal-vs-Grade 3 |
4.073200E-01 |
| Normal-vs-Grade 4 |
4.007800E-02 |
| Grade 1-vs-Grade 2 |
1.310360E-01 |
| Grade 1-vs-Grade 3 |
6.579700E-04 |
| Grade 1-vs-Grade 4 |
1.831050E-04 |
| Grade 2-vs-Grade 3 |
5.50069999999403E-05 |
| Grade 2-vs-Grade 4 |
1.76890000003205E-06 |
| Grade 3-vs-Grade 4 |
6.193700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.949730E-02 |
| Normal-vs-ccB subtype |
8.388000E-01 |
| ccA subtype-vs-ccB subtype |
1.724480E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.606400E-01 |
| Normal-vs-N1 |
9.258000E-01 |
| N0-vs-N1 |
7.484000E-01 |
|
|
